Control of stem cell renewal and fate by YAP and TAZ

JH Driskill, D Pan - Nature Reviews Molecular Cell Biology, 2023 - nature.com
Complex physiological processes control whether stem cells self-renew, differentiate or
remain quiescent. Two decades of research have placed the Hippo pathway, a highly …

The Hippo signaling pathway in development and disease

Y Zheng, D Pan - Developmental cell, 2019 - cell.com
The Hippo signaling pathway regulates diverse physiological processes, and its dysfunction
has been implicated in an increasing number of human diseases, including cancer. Here …

Hepatocyte TAZ/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis

X Wang, ZE Zheng, JM Caviglia, KE Corey, TM Herfel… - Cell metabolism, 2016 - cell.com
Nonalcoholic steatohepatitis (NASH) is a leading cause of liver disease worldwide.
However, the molecular basis of how benign steatosis progresses to NASH is incompletely …

The Hippo pathway in liver homeostasis and pathophysiology

JH Driskill, D Pan - Annual review of pathology: mechanisms of …, 2021 - annualreviews.org
Studies of the regenerative capacity of the liver have converged on the Hippo pathway, a
serine/threonine kinase cascade discovered in Drosophila and conserved from unicellular …

Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models

D Lissa, N Takahashi, P Desai, I Manukyan… - Nature …, 2022 - nature.com
Molecular subtypes of small cell lung cancer (SCLC) defined by the expression of key
transcription regulators have recently been proposed in cell lines and limited number of …

Hippo signaling in the liver regulates organ size, cell fate, and carcinogenesis

SH Patel, FD Camargo, D Yimlamai - Gastroenterology, 2017 - Elsevier
The Hippo signaling pathway, also known as the Salvador− Warts− Hippo pathway, is a
regulator of organ size. The pathway takes its name from the Drosophila protein kinase …

Ivermectin, a potential anticancer drug derived from an antiparasitic drug

M Tang, X Hu, Y Wang, X Yao, W Zhang, C Yu… - Pharmacological …, 2021 - Elsevier
Ivermectin is a macrolide antiparasitic drug with a 16-membered ring that is widely used for
the treatment of many parasitic diseases such as river blindness, elephantiasis and scabies …

Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis

Y Liu, S Zhuo, Y Zhou, L Ma, Z Sun, X Wu, XW Wang… - Journal of …, 2022 - Elsevier
Background & Aims Primary liver tumors comprise distinct subtypes. A subset of intrahepatic
cholangiocarcinoma (iCCA) can arise from cell fate reprogramming of mature hepatocytes in …

YAP/TAZ activation as a target for treating metastatic cancer

JSA Warren, Y Xiao, JM Lamar - Cancers, 2018 - mdpi.com
Yes-Associated Protein (YAP) and Transcriptional Co-activator with PDZ-binding Motif (TAZ)
have both emerged as important drivers of cancer progression and metastasis. YAP and …

The Hippo pathway in normal development and cancer

M Maugeri-Saccà, R De Maria - Pharmacology & therapeutics, 2018 - Elsevier
The Hippo pathway is a central regulator of organ size and tissue homeostasis. Hippo
kinases and adaptor proteins mediate the phosphorylation and inactivation of YAP and TAZ …